SCHEMBL18796115

SCHEMBL18796115

Nc1c(F)cccc1Oc1cnc2c(F)c(F)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 1/20 0.38
▸ MAP4K4 O95819 4/20 0.34
▸ GAA P10253 1/20 0.34
▸ RCE1 Q9Y256 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.32
▸ TRPA1 O75762 1/20 0.32
▸ BACE1 P56817 3/20 0.32
▸ CTSD P07339 1/20 0.32
▸ CTSE P14091 1/20 0.32
▸ BACE2 Q9Y5Z0 1/20 0.32
▸ TNK2 Q07912 1/20 0.32
▸ BTK Q06187 2/20 0.32
▸ CDK8 P49336 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18796266 0.88 MAP4K4 (0.36) EGLN1MAP4K4GAARCE1MEN1
SCHEMBL18796154 0.85 GAA (0.51) EGLN1MAP4K4GAARCE1MEN1
SCHEMBL18796147 0.84 EGLN1 (0.38) EGLN1MAPTCYP11B1CYP11B2KDM4E
SCHEMBL18796009 0.80 KDM4E (0.35) EGLN1MAP4K4GAARCE1MEN1
SCHEMBL18795920 0.79 MAPT (0.40) EGLN1GAAMEN1KMT2AMAPT
SCHEMBL12488153 0.79 EGLN1 (0.41) EGLN1KMT2AKDM4EABCG2
SCHEMBL12489724 0.79 EGLN1 (0.37) EGLN1MAPTCYP11B1CYP11B2KDM4E
SCHEMBL18796142 0.78 PPARG (0.43) GAARCE1MEN1KMT2A
SCHEMBL18796122 0.78 TLR8 (0.40) EGLN1MAP4K4GAARCE1MEN1
SCHEMBL23747871 0.77 L3MBTL1 (0.37) EGLN1MAP4K4MEN1KMT2ABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 — — US disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 — — US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 — — EP disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT EGLN1 706/4885MAP4K4 1977/4885GAA 298/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT EGLN1 706/4885MAP4K4 1977/4885GAA 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback